Lydia Nakiyingi - Infectious Diseases

Author Information

Lydia Nakiyingi is a researcher affiliated with the Infectious Diseases Institute at Makerere University College of Health Sciences, located in Kampala, Uganda. Her work is primarily centered on infectious diseases, with a particular focus on the challenges faced in resource-limited settings. She has contributed significantly to the understanding of various infectious diseases and their impact on both pediatric and adult populations in Uganda.

Research Contributions

Lydia Nakiyingi has made substantial contributions through her research on infectious diseases, focusing on conditions such as tuberculosis, HIV, and respiratory infections. Her work addresses clinical presentations, diagnostic challenges, and treatment outcomes, particularly in resource-limited settings. Some of her notable research includes studies on retinoblastoma in children, the impact of SARS-CoV-2 in pediatric populations, and the relationship between tuberculosis and HIV co-infection. She has also investigated ocular complications in pediatric nephrotic syndrome and the clinical learning experiences of medical students during the COVID-19 pandemic.

Aliases

Lydia Nakiyingi is known by several aliases including L Nakiyingi, L. Nakiyingi, and Lydia Nakiyingi. These variations are used in her publications and academic records.

Publication and Citation Metrics

Metric	Value
Total Citation Count	1751
H-index	18
Total Number of Papers	65

Publications:

Clinical presentation and outcomes in children with retinoblastoma managed at the Uganda Cancer Institute

DOI: 10.1155/2022/8817215

Year: 2022

SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in a Child in Uganda: A Paediatric Experience in a Resource-Limited Setting

DOI: 10.1155/2022/7811891

Year: 2022

Active Mycobacterium tuberculosis Co-Infection Associates With Higher HIV-1-Specific Antibody Responses

DOI: 10.2139/ssrn.4023683

Year: 2022

Acute Respiratory Distress Syndrome in an African Intensive Care Unit Setting: A Prospective Study of Prevalence and Outcomes.

DOI: 10.1513/AnnalsATS.202103-270RL

Year: 2021

Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting

DOI: 10.1186/s12879-020-05752-7

Year: 2021

Prevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment in a resource-limited setting

DOI: 10.1186/s12886-021-01817-6

Year: 2021

Internal Medicine Clerkship Amidst COVID-19 Pandemic: A Cross-Sectional Study of the Clinical Learning Experience of Undergraduate Medical Students at Makerere University, Uganda

DOI: 10.2147/AMEP.S300265

Year: 2021

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

DOI: 10.1016/j.jctube.2021.100286

Year: 2021

Epidemiology and Clinical Outcomes of Adults with Acute Respiratory Failure in a Low-Income Country: A Prospective, Observational, Multicentre Cohort Study

DOI: 10.2139/ssrn.3968913

Year: 2021

Factors associated with delayed uptake of cataract surgery among adult patients at Mulago National Referral Hospital, Uganda

DOI: 10.4314/ahs.v21i3.36

Year: 2021

How Can Zoonotic Diseases be Prevented?

What is Ebola?

What Strategies Does the RBM Partnership Employ?

What should be done if a condom fails?

How Can Rabies Be Prevented?

How Do Pathogens Exploit Fatty Acid Synthesis?

What Are the Key Components of a One Health Approach?

How is Salmonella Diagnosed?

What are the Side Effects?

What are the symptoms of Plasmodium falciparum malaria?

Partnered Content Networks

Relevant Topics